StockGlow

Genprex, Inc. (GNPX)

Develops gene therapies to treat cancer and diabetes by delivering disease-fighting genes into patients' bodies

$8.03+0.04%Healthcare
Compare GNPX with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-96.8%

The outlook

GNPX is trading near its 52-week low, well below both its 50- and 200-day moving averages. Analyst coverage appears minimal, and the overall sentiment leans bearish. The stock sits at the very bottom of its yearly range.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$4.1M
52-wk high
$1,210.00
52-wk low
$6.72
50-day avg
$12.99
200-day avg
$61.02
Trailing P/E
—

Similar stocks

CODXCo-Diagnostics, Inc.$1.41-30.88%DAREDaré Bioscience, Inc.$1.19-10.23%AIMAIM ImmunoTech Inc.$0.24-5.60%NNVCNanoViricides, Inc.$1.61+4.55%AYTUAytu BioPharma, Inc.$2.13+3.40%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy